Main Session: Nuances in the Management of Aggressive Lymphomas

How does genetic information affect treatment decisions in aggressive lymphoma, such as DLBCL?

Paul Hamlin, MD
Memorial Sloan Kettering Cancer Center

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here